发明授权
- 专利标题: Compositions for inhibiting gene expression and uses thereof
- 专利标题(中): 用于抑制基因表达的组合物及其用途
-
申请号: US13072017申请日: 2011-03-25
-
公开(公告)号: US08877722B2公开(公告)日: 2014-11-04
- 发明人: Sudhir Agrawal , Ekambar Kandimalla , Mallikarjuna Putta , Ireneusz Nowak , Nicola LaMonica , Weiwen Jiang , Michael Reardon , Tao Lan
- 申请人: Sudhir Agrawal , Ekambar Kandimalla , Mallikarjuna Putta , Ireneusz Nowak , Nicola LaMonica , Weiwen Jiang , Michael Reardon , Tao Lan
- 申请人地址: US MA Cambridge
- 专利权人: Idera Pharmaceuticals, Inc.
- 当前专利权人: Idera Pharmaceuticals, Inc.
- 当前专利权人地址: US MA Cambridge
- 代理机构: McDonnell Boehnen Hulbert & Berghoff LLP
- 主分类号: A61K48/00
- IPC分类号: A61K48/00 ; C07H21/02 ; C07H21/04
摘要:
The inventors have examined the means for providing more efficacious miRNA blocking compounds. The inventors have discovered new structural features that surprisingly improve the efficacy of miRNA blocking molecules. These features include the presence of multiple 3′ ends and a linker at the 5′ ends. Surprisingly, these features improve the efficacy of the gene expression blocking compounds in a manner that decreases the compound's biologic instability. Even more surprisingly, this effect has been found to be applicable to both DNA and RNA oligonucleotide-based compounds and to have application in traditional antisense and RNAi technology.
公开/授权文献
信息查询